Inverse relationship between fasting direct bilirubin and metabolic syndrome in Korean adults

Studies on the effects of bilirubin on cardiovascular disease have typically focused only on total serum bilirubin composed with direct bilirubin plus indirect bilirubin. In this study, we examined which type of fasting bilirubin is more associated with the metabolic syndrome (MS). Five thousand six...

Full description

Saved in:
Bibliographic Details
Published inClinica chimica acta Vol. 411; no. 19; pp. 1496 - 1501
Main Authors Hwang, Hee-Jin, Kim, Sang-Hwan
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 09.10.2010
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Studies on the effects of bilirubin on cardiovascular disease have typically focused only on total serum bilirubin composed with direct bilirubin plus indirect bilirubin. In this study, we examined which type of fasting bilirubin is more associated with the metabolic syndrome (MS). Five thousand six hundred and fifty-four individuals who visited the Center for Health Promotion for a periodic medical health check-up were screened for inclusion in the study. We excluded subjects who had a chronic viral liver disease, an alcoholic liver disease, or an abnormal liver function defined as a serum aspartate aminotransferase or alanine aminotransferase > 100 IU/l, a gamma glutamyltransferase > 100 IU/l, or a fasting total bilirubin level > 3 mg/dl. In men, only fasting direct bilirubin levels decreased with an increase in the number of MS components (p = 0.001). However, all three types of fasting bilirubin decreased when the subjects had more components of MS (p < 0.001) in women. Both in men and women fasting direct bilirubin levels were related with the MS (p for trend = 0.003 in men and < 0.001 in women) after the adjustments for age, body mass index, smoking, alcohol drinking, exercise habits, and presence of fatty liver. The odds ratio (95% confidence interval) of MS for each fasting direct bilirubin quartile was 0.88 (0.59–1.29), 0.63 (0.42–0.95), 0.61 (0.38–0.97) in men, and 0.66 (0.50–0.87), 0.52 (0.35–0.78), 0.27 (0.12–0.59) in women, respectively. However, fasting total and indirect bilirubin levels were related with the MS in women, but not in men. Our findings suggest that MS is more related to the fasting direct bilirubin in Korean adults than the other types of fasting bilirubin.
AbstractList Studies on the effects of bilirubin on cardiovascular disease have typically focused only on total serum bilirubin composed with direct bilirubin plus indirect bilirubin. In this study, we examined which type of fasting bilirubin is more associated with the metabolic syndrome (MS). Five thousand six hundred and fifty-four individuals who visited the Center for Health Promotion for a periodic medical health check-up were screened for inclusion in the study. We excluded subjects who had a chronic viral liver disease, an alcoholic liver disease, or an abnormal liver function defined as a serum aspartate aminotransferase or alanine aminotransferase > 100 IU/l, a gamma glutamyltransferase > 100 IU/l, or a fasting total bilirubin level > 3 mg/dl. In men, only fasting direct bilirubin levels decreased with an increase in the number of MS components (p = 0.001). However, all three types of fasting bilirubin decreased when the subjects had more components of MS (p < 0.001) in women. Both in men and women fasting direct bilirubin levels were related with the MS (p for trend = 0.003 in men and < 0.001 in women) after the adjustments for age, body mass index, smoking, alcohol drinking, exercise habits, and presence of fatty liver. The odds ratio (95% confidence interval) of MS for each fasting direct bilirubin quartile was 0.88 (0.59–1.29), 0.63 (0.42–0.95), 0.61 (0.38–0.97) in men, and 0.66 (0.50–0.87), 0.52 (0.35–0.78), 0.27 (0.12–0.59) in women, respectively. However, fasting total and indirect bilirubin levels were related with the MS in women, but not in men. Our findings suggest that MS is more related to the fasting direct bilirubin in Korean adults than the other types of fasting bilirubin.
Studies on the effects of bilirubin on cardiovascular disease have typically focused only on total serum bilirubin composed with direct bilirubin plus indirect bilirubin. In this study, we examined which type of fasting bilirubin is more associated with the metabolic syndrome (MS). Five thousand six hundred and fifty-four individuals who visited the Center for Health Promotion for a periodic medical health check-up were screened for inclusion in the study. We excluded subjects who had a chronic viral liver disease, an alcoholic liver disease, or an abnormal liver function defined as a serum aspartate aminotransferase or alanine aminotransferase >100IU/l, a gamma glutamyltransferase >100IU/l, or a fasting total bilirubin level >3mg/dl. In men, only fasting direct bilirubin levels decreased with an increase in the number of MS components (p=0.001). However, all three types of fasting bilirubin decreased when the subjects had more components of MS (p<0.001) in women. Both in men and women fasting direct bilirubin levels were related with the MS (p for trend=0.003 in men and <0.001 in women) after the adjustments for age, body mass index, smoking, alcohol drinking, exercise habits, and presence of fatty liver. The odds ratio (95% confidence interval) of MS for each fasting direct bilirubin quartile was 0.88 (0.59-1.29), 0.63 (0.42-0.95), 0.61 (0.38-0.97) in men, and 0.66 (0.50-0.87), 0.52 (0.35-0.78), 0.27 (0.12-0.59) in women, respectively. However, fasting total and indirect bilirubin levels were related with the MS in women, but not in men. Our findings suggest that MS is more related to the fasting direct bilirubin in Korean adults than the other types of fasting bilirubin.
Studies on the effects of bilirubin on cardiovascular disease have typically focused only on total serum bilirubin composed with direct bilirubin plus indirect bilirubin. In this study, we examined which type of fasting bilirubin is more associated with the metabolic syndrome (MS).BACKGROUNDStudies on the effects of bilirubin on cardiovascular disease have typically focused only on total serum bilirubin composed with direct bilirubin plus indirect bilirubin. In this study, we examined which type of fasting bilirubin is more associated with the metabolic syndrome (MS).Five thousand six hundred and fifty-four individuals who visited the Center for Health Promotion for a periodic medical health check-up were screened for inclusion in the study. We excluded subjects who had a chronic viral liver disease, an alcoholic liver disease, or an abnormal liver function defined as a serum aspartate aminotransferase or alanine aminotransferase >100IU/l, a gamma glutamyltransferase >100IU/l, or a fasting total bilirubin level >3mg/dl.METHODSFive thousand six hundred and fifty-four individuals who visited the Center for Health Promotion for a periodic medical health check-up were screened for inclusion in the study. We excluded subjects who had a chronic viral liver disease, an alcoholic liver disease, or an abnormal liver function defined as a serum aspartate aminotransferase or alanine aminotransferase >100IU/l, a gamma glutamyltransferase >100IU/l, or a fasting total bilirubin level >3mg/dl.In men, only fasting direct bilirubin levels decreased with an increase in the number of MS components (p=0.001). However, all three types of fasting bilirubin decreased when the subjects had more components of MS (p<0.001) in women. Both in men and women fasting direct bilirubin levels were related with the MS (p for trend=0.003 in men and <0.001 in women) after the adjustments for age, body mass index, smoking, alcohol drinking, exercise habits, and presence of fatty liver. The odds ratio (95% confidence interval) of MS for each fasting direct bilirubin quartile was 0.88 (0.59-1.29), 0.63 (0.42-0.95), 0.61 (0.38-0.97) in men, and 0.66 (0.50-0.87), 0.52 (0.35-0.78), 0.27 (0.12-0.59) in women, respectively. However, fasting total and indirect bilirubin levels were related with the MS in women, but not in men.RESULTSIn men, only fasting direct bilirubin levels decreased with an increase in the number of MS components (p=0.001). However, all three types of fasting bilirubin decreased when the subjects had more components of MS (p<0.001) in women. Both in men and women fasting direct bilirubin levels were related with the MS (p for trend=0.003 in men and <0.001 in women) after the adjustments for age, body mass index, smoking, alcohol drinking, exercise habits, and presence of fatty liver. The odds ratio (95% confidence interval) of MS for each fasting direct bilirubin quartile was 0.88 (0.59-1.29), 0.63 (0.42-0.95), 0.61 (0.38-0.97) in men, and 0.66 (0.50-0.87), 0.52 (0.35-0.78), 0.27 (0.12-0.59) in women, respectively. However, fasting total and indirect bilirubin levels were related with the MS in women, but not in men.Our findings suggest that MS is more related to the fasting direct bilirubin in Korean adults than the other types of fasting bilirubin.CONCLUSIONOur findings suggest that MS is more related to the fasting direct bilirubin in Korean adults than the other types of fasting bilirubin.
Author Kim, Sang-Hwan
Hwang, Hee-Jin
Author_xml – sequence: 1
  givenname: Hee-Jin
  surname: Hwang
  fullname: Hwang, Hee-Jin
– sequence: 2
  givenname: Sang-Hwan
  surname: Kim
  fullname: Kim, Sang-Hwan
  email: fanink@naver.com
BackLink https://www.ncbi.nlm.nih.gov/pubmed/20542021$$D View this record in MEDLINE/PubMed
BookMark eNp9kE1v1DAQQK2qVbst_AAuyDdOWcax4yTihKpCKypxKUdk-WMCXiX2Yjut-u9x2cKBQ0-j0bw3h3dOjkMMSMgbBlsGTL7fba3V2xbqDnILwI_Ihg09b7gY22OyAYCxGcaBnZHznHd1FSDZKTlroRMttGxDvt-Ee0wZacJZFx9D_un31GB5QAx00rn48IM6n9AWavzs02p8oDo4umDRJs7e0vwYXIoL0nr5EhPqCrh1LvkVOZn0nPH187wg3z5d3V1eN7dfP99cfrxtrGBDaeQIThhuYGSdGG3vZKe5Mb3UjHeci16LiYu2Y2ARZM87OfbIjOVTNwk3TfyCvDv83af4a8Vc1OKzxXnWAeOaVS9GYINgUMm3z-RqFnRqn_yi06P6W6QC7ADYFHNOOP1DGKin6mqnanX1VF2BVLV6dfr_HOvLn5olaT-_aH44mFjr3HtMKluPweKhuHLRv2D_Bpdqm74
CitedBy_id crossref_primary_10_1249_MSS_0b013e3182357dd4
crossref_primary_10_1371_journal_pone_0075178
crossref_primary_10_1186_s12944_018_0857_7
crossref_primary_10_9758_cpn_2017_15_2_153
crossref_primary_10_1016_j_plipres_2012_11_001
crossref_primary_10_1089_jwh_2010_2453
crossref_primary_10_1016_j_jdiacomp_2018_09_002
crossref_primary_10_1016_j_metabol_2013_01_011
crossref_primary_10_1152_ajprenal_00039_2014
crossref_primary_10_1007_s11906_017_0756_8
crossref_primary_10_1177_2042018820937897
crossref_primary_10_1016_j_clinbiochem_2011_12_023
crossref_primary_10_1016_j_freeradbiomed_2012_03_002
crossref_primary_10_1155_2017_9621615
crossref_primary_10_3389_fendo_2022_869579
crossref_primary_10_1093_eurheartj_ehv114
crossref_primary_10_4103_jrms_JRMS_198_18
crossref_primary_10_1038_s41598_019_51043_w
crossref_primary_10_3389_fpubh_2022_1003505
crossref_primary_10_1016_j_atherosclerosis_2014_12_042
crossref_primary_10_1002_gepi_21711
crossref_primary_10_1007_s00592_016_0946_x
crossref_primary_10_3389_fpubh_2021_743731
crossref_primary_10_1016_j_jdiacomp_2016_05_013
crossref_primary_10_2147_DMSO_S391777
crossref_primary_10_1186_s13098_019_0408_z
crossref_primary_10_1038_srep41338
crossref_primary_10_1007_s12020_010_9417_2
crossref_primary_10_1016_j_dsx_2019_02_009
crossref_primary_10_14260_jemds_2016_1353
crossref_primary_10_30548_vascfail_3_2_51
crossref_primary_10_1016_j_diabet_2014_04_006
crossref_primary_10_2139_ssrn_3746287
crossref_primary_10_1371_journal_pone_0037241
crossref_primary_10_1155_2014_175286
crossref_primary_10_1016_j_atherosclerosis_2017_12_021
crossref_primary_10_1097_BSD_0000000000000140
crossref_primary_10_1016_j_diabet_2016_06_002
crossref_primary_10_1371_journal_pone_0098467
crossref_primary_10_1016_j_atherosclerosis_2015_11_008
crossref_primary_10_1016_j_numecd_2011_03_001
crossref_primary_10_3109_15368378_2013_773909
crossref_primary_10_3346_jkms_2014_29_S2_S155
crossref_primary_10_1186_s12967_022_03309_7
crossref_primary_10_1016_j_biopha_2016_02_017
crossref_primary_10_1161_ATVBAHA_113_303003
crossref_primary_10_1089_met_2015_0113
crossref_primary_10_3390_jcm10132812
crossref_primary_10_1016_j_atherosclerosis_2011_07_094
crossref_primary_10_1016_j_numecd_2018_05_013
crossref_primary_10_1371_journal_pone_0094479
Cites_doi 10.1093/clinchem/40.1.18
10.1161/01.ATV.16.2.250
10.1016/S0021-9150(97)06088-7
10.1016/0006-2952(95)02395-X
10.1016/S0893-133X(01)00275-5
10.1161/HYPERTENSIONAHA.107.092296
10.1016/j.diabres.2006.04.013
10.1093/aje/kwf145
10.1016/S0002-9149(99)00491-9
10.1016/S0008-6363(98)00278-8
10.1016/j.atherosclerosis.2005.05.011
10.1126/science.3029864
10.1161/01.CIR.0000111245.75752.C6
10.1016/j.atherosclerosis.2008.07.021
10.1161/CIRCULATIONAHA.104.528802
10.1016/S0065-2423(06)43001-8
10.1126/science.7678183
10.1161/01.ATV.17.6.1121
10.1161/01.CIR.99.2.237
10.1373/49.7.1201
10.1016/S0021-9258(19)89449-8
10.2174/138161208783597335
10.2337/db07-1764
10.2337/diabetes.51.10.3120
10.1210/jc.82.12.4196
10.1073/pnas.252626999
10.1016/S0065-2776(08)60379-X
10.1002/j.1550-8528.1997.tb00650.x
10.1016/S0022-2143(98)90168-8
10.1016/S0002-9149(01)01494-1
10.1016/j.metabol.2009.04.003
10.1161/CIRCULATIONAHA.105.169404
10.1038/sj.ejhg.5200842
10.1016/0304-4165(93)90013-X
10.1097/01.hjr.0000230097.81202.9f
10.1016/S0021-9150(97)00232-3
10.1016/S0021-9150(01)00601-3
10.1152/ajprenal.00278.2004
10.1161/01.ATV.0000178169.95781.49
10.1023/A:1013794407325
10.1161/ATVBAHA.107.153262
10.1016/j.atherosclerosis.2007.11.022
ContentType Journal Article
Copyright 2010 Elsevier B.V.
Copyright 2010 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2010 Elsevier B.V.
– notice: Copyright 2010 Elsevier B.V. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.cca.2010.06.003
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
EISSN 1873-3492
EndPage 1501
ExternalDocumentID 20542021
10_1016_j_cca_2010_06_003
S0009898110003827
Genre Journal Article
GroupedDBID ---
--K
--M
.55
.GJ
.~1
0R~
1B1
1RT
1~.
1~5
29B
4.4
457
4G.
53G
5GY
5VS
6J9
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXUO
ABBQC
ABFNM
ABFRF
ABGSF
ABJNI
ABLVK
ABMAC
ABMZM
ABUDA
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AHPSJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
DOVZS
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
G8K
GBLVA
HLW
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
LCYCR
LX3
M41
MO0
N9A
O-L
O9-
OAUVE
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
RNS
ROL
RPZ
SBG
SDF
SDG
SDP
SES
SEW
SPCBC
SSH
SSU
SSZ
T5K
WH7
WUQ
X7M
XPP
ZA5
ZGI
~02
~G-
AATTM
AAXKI
AAYWO
AAYXX
ABDPE
ABWVN
ACIEU
ACRPL
ACVFH
ADCNI
ADNMO
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c418t-690d4b3b091549c7d65a3bb76a1353347a4f342510ce06735697e1bc3f5f4dff3
IEDL.DBID .~1
ISSN 0009-8981
1873-3492
IngestDate Fri Jul 11 16:53:57 EDT 2025
Thu Apr 03 07:10:20 EDT 2025
Tue Jul 01 01:16:32 EDT 2025
Thu Apr 24 23:05:48 EDT 2025
Fri Feb 23 02:28:46 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 19
Keywords Bilirubin
Direct bilirubin
Metabolic syndrome
Indirect bilirubin
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
Copyright 2010 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c418t-690d4b3b091549c7d65a3bb76a1353347a4f342510ce06735697e1bc3f5f4dff3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 20542021
PQID 749018410
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_749018410
pubmed_primary_20542021
crossref_primary_10_1016_j_cca_2010_06_003
crossref_citationtrail_10_1016_j_cca_2010_06_003
elsevier_sciencedirect_doi_10_1016_j_cca_2010_06_003
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-10-09
PublicationDateYYYYMMDD 2010-10-09
PublicationDate_xml – month: 10
  year: 2010
  text: 2010-10-09
  day: 09
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Clinica chimica acta
PublicationTitleAlternate Clin Chim Acta
PublicationYear 2010
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Endler, Hamwi, Sunder-Plassmann (bib28) 2003; 49
Jaundice (bib10) 2006
Li, Kim, Tsenovoy (bib36) 2008; 57
Ollinger, Bilban, Erat (bib39) 2005; 112
Hopkins, Wu, Hunt (bib14) 1996; 16
Perlstein, Pande, Beckman (bib16) 2008; 28
Andersson, Weeke, Fosbøl (bib40) 2009; 58
Hotamisligil, Shargill, Spiegelman (bib6) 1993; 259
Stocker, Yamamoto, McDonagh (bib29) 1987; 235
Pflueger, Croatt, Peterson (bib37) 2005; 288
Datla, Dusting, Mori (bib38) 2007; 50
Koenig, Sund, Fröhlich (bib8) 1999; 99
Kronenberg, Coon, Gutin (bib27) 2002; 10
Wu, Fung, Wu, Vítek, Schwertner (bib32) 1996; 51
Schwertner, Morita (bib33) 1998; 136
Hanson, Imperatore, Bennett (bib3) 2002; 51
Troughton, Woodside, Young (bib19) 2007; 14
Nakagami, Toyomura, Kinoshita, Wolkoff (bib30) 1993; 1158
Grundy, Brewer, Cleeman (bib1) 2004; 109
Erdogan, Gullu, Yildirim (bib15) 2006; 184
Tokuda, Tanimoto (bib24) 1993; 22
Laaksonen, Lakka, Niskanen (bib2) 2002; 156
Mohamed-Ali, Goodrick, Rawesh (bib5) 1997; 82
Lee, Park, Kim (bib25) 2007; 75
Djousse, Levy, Cupples (bib17) 2001; 87
Vítek, Jirsa, Brodanová, Siow, Sato, Mann (bib34) 2002; 160
Rohde, Hennekens, Ridker (bib9) 1999; 84
Bulmer, Blanchfield, Toth (bib12) 2008; 199
Madhavan, Wattingney, Srinivasan (bib20) 1997; 131
Baranano, Rao, Ferris (bib11) 2002; 99
Torgerson, Lindroos, Sjostrom (bib21) 1997; 5
Lin, Kuo, Hwang (bib22) 2009; 203
Pepys, Baltz, Snyder, Barañano (bib35) 1983; 34
Temme, Zhang, Schouten, Kesteloot (bib18) 2001; 12
Schwertner, Jackson, Tolan (bib13) 1994; 40
Neuzil, Stocker, Chung, Pae, Cha (bib31) 1994; 269
Troughton, Woodside, Young (bib26) 2007; 14
Grundy, Cleeman, Daniels (bib4) 2005; 112
Tracy, Lemaitre, Psaty (bib7) 1997; 17
Okada, Matsui, Ito (bib23) 1998; 132
Schwertner (10.1016/j.cca.2010.06.003_bib13) 1994; 40
Troughton (10.1016/j.cca.2010.06.003_bib26) 2007; 14
Wu (10.1016/j.cca.2010.06.003_bib32_1) 1996; 51
Vítek (10.1016/j.cca.2010.06.003_bib34_1) 2002; 160
Hanson (10.1016/j.cca.2010.06.003_bib3) 2002; 51
Grundy (10.1016/j.cca.2010.06.003_bib1) 2004; 109
Neuzil (10.1016/j.cca.2010.06.003_bib31_1) 1994; 269
Pflueger (10.1016/j.cca.2010.06.003_bib37) 2005; 288
Bulmer (10.1016/j.cca.2010.06.003_bib12) 2008; 199
Madhavan (10.1016/j.cca.2010.06.003_bib20) 1997; 131
Tracy (10.1016/j.cca.2010.06.003_bib7) 1997; 17
Schwertner (10.1016/j.cca.2010.06.003_bib33_1) 1998; 136
Stocker (10.1016/j.cca.2010.06.003_bib29) 1987; 235
Vítek (10.1016/j.cca.2010.06.003_bib32_2) 2007; 43
Endler (10.1016/j.cca.2010.06.003_bib28) 2003; 49
Baranano (10.1016/j.cca.2010.06.003_bib11) 2002; 99
Troughton (10.1016/j.cca.2010.06.003_bib19) 2007; 14
Siow (10.1016/j.cca.2010.06.003_bib34_2) 1999; 41
Djousse (10.1016/j.cca.2010.06.003_bib17) 2001; 87
Erdogan (10.1016/j.cca.2010.06.003_bib15) 2006; 184
Jaundice (10.1016/j.cca.2010.06.003_bib10) 2006
Lin (10.1016/j.cca.2010.06.003_bib22) 2009; 203
Hotamisligil (10.1016/j.cca.2010.06.003_bib6) 1993; 259
Chung (10.1016/j.cca.2010.06.003_bib31_2) 2008; 14
Ollinger (10.1016/j.cca.2010.06.003_bib39) 2005; 112
Rohde (10.1016/j.cca.2010.06.003_bib9) 1999; 84
Datla (10.1016/j.cca.2010.06.003_bib38) 2007; 50
Koenig (10.1016/j.cca.2010.06.003_bib8) 1999; 99
Lee (10.1016/j.cca.2010.06.003_bib25) 2007; 75
Temme (10.1016/j.cca.2010.06.003_bib18) 2001; 12
Laaksonen (10.1016/j.cca.2010.06.003_bib2) 2002; 156
Okada (10.1016/j.cca.2010.06.003_bib23) 1998; 132
Tokuda (10.1016/j.cca.2010.06.003_bib24) 1993; 22
Torgerson (10.1016/j.cca.2010.06.003_bib21) 1997; 5
Wolkoff (10.1016/j.cca.2010.06.003_bib30_2) 2005
Morita (10.1016/j.cca.2010.06.003_bib33_2) 2005; 25
Nakagami (10.1016/j.cca.2010.06.003_bib30_1) 1993; 1158
Grundy (10.1016/j.cca.2010.06.003_bib4) 2005; 112
Li (10.1016/j.cca.2010.06.003_bib36) 2008; 57
Hopkins (10.1016/j.cca.2010.06.003_bib14) 1996; 16
Perlstein (10.1016/j.cca.2010.06.003_bib16) 2008; 28
Pepys (10.1016/j.cca.2010.06.003_bib35_1) 1983; 34
Andersson (10.1016/j.cca.2010.06.003_bib40) 2009; 58
Mohamed-Ali (10.1016/j.cca.2010.06.003_bib5) 1997; 82
Snyder (10.1016/j.cca.2010.06.003_bib35_2) 2001; 25
Kronenberg (10.1016/j.cca.2010.06.003_bib27) 2002; 10
References_xml – volume: 136
  start-page: 383
  year: 1998
  end-page: 387
  ident: bib33
  article-title: Association of smoking and low serum bilirubin antioxidant concentrations
  publication-title: Atherosclerosis
– volume: 50
  start-page: 636
  year: 2007
  end-page: 642
  ident: bib38
  article-title: Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase derived oxidative stress
  publication-title: Hypertension
– volume: 40
  start-page: 18
  year: 1994
  end-page: 23
  ident: bib13
  article-title: Association of low serum concentration of bilirubin with increased risk of coronary artery disease
  publication-title: Clin Chem
– volume: 184
  start-page: 431
  year: 2006
  end-page: 437
  ident: bib15
  article-title: Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women
  publication-title: Atherosclerosis
– volume: 99
  start-page: 237
  year: 1999
  end-page: 242
  ident: bib8
  article-title: C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992
  publication-title: Circulation
– volume: 28
  start-page: 166
  year: 2008
  end-page: 172
  ident: bib16
  article-title: Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004
  publication-title: Arterioscler Thromb Vasc Biol
– volume: 14
  start-page: 79
  year: 2007
  end-page: 84
  ident: bib19
  article-title: Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction (PRIME)
  publication-title: Eur J Cardiovasc Prev Rehabil
– volume: 22
  start-page: 116
  year: 1993
  end-page: 122
  ident: bib24
  article-title: New method of measuring serum bilirubin using vanadic acid
  publication-title: Jpn J Clin Chem
– volume: 131
  start-page: 107
  year: 1997
  end-page: 113
  ident: bib20
  article-title: Serum bilirubin distribution and its relation to cardiovascular risk in children and young adults
  publication-title: Atherosclerosis
– volume: 235
  start-page: 1043
  year: 1987
  end-page: 1046
  ident: bib29
  article-title: Bilirubin is an antioxidant of possible physiological importance
  publication-title: Science
– volume: 99
  start-page: 16093
  year: 2002
  end-page: 16098
  ident: bib11
  article-title: Biliverdin reductase: a major physiologic cytoprotectant
  publication-title: Proc Natl Acad Sci U S A
– volume: 49
  start-page: 1201
  year: 2003
  end-page: 1204
  ident: bib28
  article-title: Is low serum bilirubin an independent risk factor for coronary artery disease in men but not in women?
  publication-title: Clin Chem
– volume: 5
  start-page: 105
  year: 1997
  end-page: 114
  ident: bib21
  article-title: Are elevated aminotransferases and decreased bilirubin additional characteristics of the metabolic syndrome?
  publication-title: Obes Res
– volume: 10
  start-page: 539
  year: 2002
  end-page: 546
  ident: bib27
  article-title: A genome scan for loci influencing anti-atherogenic serum bilirubin levels
  publication-title: Eur J Hum Genet
– volume: 288
  start-page: 552
  year: 2005
  end-page: 558
  ident: bib37
  article-title: The hyperbilirubinemic Gunn rat is resistant to the pressor effects of angiotensin II
  publication-title: Am J Physiol Ren Physiol
– volume: 12
  start-page: 887
  year: 2001
  end-page: 894
  ident: bib18
  article-title: Serum bilirubin and 10-year mortality risk in a Belgian population
  publication-title: Cancer Causes Control
– volume: 14
  start-page: 79
  year: 2007
  end-page: 84
  ident: bib26
  article-title: Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction (PRIME)
  publication-title: Eur J Cardiovasc Prev Rehabil
– volume: 58
  start-page: 1109
  year: 2009
  end-page: 1115
  ident: bib40
  article-title: Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial
  publication-title: Metabolism
– volume: 17
  start-page: 1121
  year: 1997
  end-page: 1127
  ident: bib7
  article-title: Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the cardiovascular health study and the rural health promotion project
  publication-title: Arterioscler Thromb Vasc Biol
– volume: 87
  start-page: 1196
  year: 2001
  end-page: 1200
  ident: bib17
  article-title: Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study
  publication-title: Am J Cardiol
– volume: 203
  start-page: 563
  year: 2009
  end-page: 568
  ident: bib22
  article-title: Serum bilirubin is inversely associated with insulin resistance and metabolic syndrome among children and adolescents
  publication-title: Atherosclerosis
– volume: 57
  start-page: 1526
  year: 2008
  end-page: 1535
  ident: bib36
  article-title: Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance
  publication-title: Diabetes
– volume: 269
  start-page: 16712
  year: 1994
  end-page: 16719
  ident: bib31
  article-title: Free and albumin-bound bilirubin are efficient coantioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation
  publication-title: J Biol Chem
– volume: 112
  start-page: 1030
  year: 2005
  end-page: 1039
  ident: bib39
  article-title: Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation
  publication-title: Circulation
– volume: 109
  start-page: 433
  year: 2004
  end-page: 438
  ident: bib1
  article-title: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition
  publication-title: Circulation
– volume: 1158
  start-page: 189
  year: 1993
  end-page: 193
  ident: bib30
  article-title: A beneficial role of bile pigments as an endogenous tissue protector: anticomplement effects of biliverdin and conjugated bilirubin
  publication-title: Biochim Biophys Acta
– volume: 156
  start-page: 1070
  year: 2002
  end-page: 1077
  ident: bib2
  article-title: Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study
  publication-title: Am J Epidemiol
– volume: 259
  start-page: 87
  year: 1993
  end-page: 91
  ident: bib6
  article-title: Adipose expression of tumor necrosis factor-alpha: direct role in obesity linked insulin resistance
  publication-title: Science
– volume: 16
  start-page: 250
  year: 1996
  end-page: 255
  ident: bib14
  article-title: Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease
  publication-title: Arterioscler Thromb Vasc Biol
– volume: 84
  start-page: 1018
  year: 1999
  end-page: 1022
  ident: bib9
  article-title: Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men
  publication-title: Am J Cardiol
– volume: 160
  start-page: 449
  year: 2002
  end-page: 456
  ident: bib34
  article-title: Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels
  publication-title: Atherosclerosis
– start-page: 301
  year: 2006
  end-page: 314
  ident: bib10
  publication-title: Sleisenger and Fordtran's gastrointestinal and liver disease
– volume: 82
  start-page: 4196
  year: 1997
  end-page: 4200
  ident: bib5
  article-title: Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo
  publication-title: J Clin Endocrinol Metab
– volume: 112
  start-page: 2735
  year: 2005
  end-page: 2752
  ident: bib4
  article-title: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement
  publication-title: Circulation
– volume: 34
  start-page: 141
  year: 1983
  end-page: 212
  ident: bib35
  article-title: Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein
  publication-title: Adv Immunol
– volume: 51
  start-page: 3120
  year: 2002
  end-page: 3127
  ident: bib3
  article-title: Components of the metabolic syndrome and incidence of type 2 diabetes
  publication-title: Diabetes
– volume: 132
  start-page: 195
  year: 1998
  end-page: 201
  ident: bib23
  article-title: Low density lipoprotein cholesterol can be chemically measured: a new superior method
  publication-title: J Lab Clin Med
– volume: 75
  start-page: 72
  year: 2007
  end-page: 80
  ident: bib25
  article-title: Appropriate waist circumference cutoff points for central obesity in Korean adults
  publication-title: Diab Res Clin Pract
– volume: 51
  start-page: 859
  year: 1996
  end-page: 862
  ident: bib32
  article-title: Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins
  publication-title: Biochem Pharmacol
– volume: 199
  start-page: 390
  year: 2008
  end-page: 396
  ident: bib12
  article-title: Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection
  publication-title: Atherosclerosis
– volume: 40
  start-page: 18
  year: 1994
  ident: 10.1016/j.cca.2010.06.003_bib13
  article-title: Association of low serum concentration of bilirubin with increased risk of coronary artery disease
  publication-title: Clin Chem
  doi: 10.1093/clinchem/40.1.18
– volume: 16
  start-page: 250
  year: 1996
  ident: 10.1016/j.cca.2010.06.003_bib14
  article-title: Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.16.2.250
– volume: 131
  start-page: 107
  year: 1997
  ident: 10.1016/j.cca.2010.06.003_bib20
  article-title: Serum bilirubin distribution and its relation to cardiovascular risk in children and young adults
  publication-title: Atherosclerosis
  doi: 10.1016/S0021-9150(97)06088-7
– volume: 51
  start-page: 859
  year: 1996
  ident: 10.1016/j.cca.2010.06.003_bib32_1
  article-title: Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins
  publication-title: Biochem Pharmacol
  doi: 10.1016/0006-2952(95)02395-X
– start-page: 1817
  year: 2005
  ident: 10.1016/j.cca.2010.06.003_bib30_2
  article-title: The hyperbilirubinemias: Harrison's principles of internal medicine
– volume: 25
  start-page: 294
  year: 2001
  ident: 10.1016/j.cca.2010.06.003_bib35_2
  article-title: Heme oxygenase: a font of multiple messengers
  publication-title: Neuropsychopharmacology
  doi: 10.1016/S0893-133X(01)00275-5
– volume: 50
  start-page: 636
  year: 2007
  ident: 10.1016/j.cca.2010.06.003_bib38
  article-title: Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase derived oxidative stress
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.107.092296
– volume: 75
  start-page: 72
  year: 2007
  ident: 10.1016/j.cca.2010.06.003_bib25
  article-title: Appropriate waist circumference cutoff points for central obesity in Korean adults
  publication-title: Diab Res Clin Pract
  doi: 10.1016/j.diabres.2006.04.013
– start-page: 301
  year: 2006
  ident: 10.1016/j.cca.2010.06.003_bib10
– volume: 156
  start-page: 1070
  year: 2002
  ident: 10.1016/j.cca.2010.06.003_bib2
  article-title: Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwf145
– volume: 84
  start-page: 1018
  year: 1999
  ident: 10.1016/j.cca.2010.06.003_bib9
  article-title: Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men
  publication-title: Am J Cardiol
  doi: 10.1016/S0002-9149(99)00491-9
– volume: 41
  start-page: 385
  year: 1999
  ident: 10.1016/j.cca.2010.06.003_bib34_2
  article-title: Heme oxygenase-carbon monoxide signaling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide?
  publication-title: Cardiovasc Res
  doi: 10.1016/S0008-6363(98)00278-8
– volume: 184
  start-page: 431
  year: 2006
  ident: 10.1016/j.cca.2010.06.003_bib15
  article-title: Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2005.05.011
– volume: 235
  start-page: 1043
  year: 1987
  ident: 10.1016/j.cca.2010.06.003_bib29
  article-title: Bilirubin is an antioxidant of possible physiological importance
  publication-title: Science
  doi: 10.1126/science.3029864
– volume: 109
  start-page: 433
  year: 2004
  ident: 10.1016/j.cca.2010.06.003_bib1
  article-title: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000111245.75752.C6
– volume: 203
  start-page: 563
  year: 2009
  ident: 10.1016/j.cca.2010.06.003_bib22
  article-title: Serum bilirubin is inversely associated with insulin resistance and metabolic syndrome among children and adolescents
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2008.07.021
– volume: 112
  start-page: 1030
  year: 2005
  ident: 10.1016/j.cca.2010.06.003_bib39
  article-title: Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.104.528802
– volume: 43
  start-page: 1
  year: 2007
  ident: 10.1016/j.cca.2010.06.003_bib32_2
  article-title: The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases
  publication-title: Adv Clin Chem
  doi: 10.1016/S0065-2423(06)43001-8
– volume: 259
  start-page: 87
  year: 1993
  ident: 10.1016/j.cca.2010.06.003_bib6
  article-title: Adipose expression of tumor necrosis factor-alpha: direct role in obesity linked insulin resistance
  publication-title: Science
  doi: 10.1126/science.7678183
– volume: 17
  start-page: 1121
  year: 1997
  ident: 10.1016/j.cca.2010.06.003_bib7
  article-title: Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the cardiovascular health study and the rural health promotion project
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.17.6.1121
– volume: 99
  start-page: 237
  year: 1999
  ident: 10.1016/j.cca.2010.06.003_bib8
  publication-title: Circulation
  doi: 10.1161/01.CIR.99.2.237
– volume: 49
  start-page: 1201
  year: 2003
  ident: 10.1016/j.cca.2010.06.003_bib28
  article-title: Is low serum bilirubin an independent risk factor for coronary artery disease in men but not in women?
  publication-title: Clin Chem
  doi: 10.1373/49.7.1201
– volume: 269
  start-page: 16712
  year: 1994
  ident: 10.1016/j.cca.2010.06.003_bib31_1
  article-title: Free and albumin-bound bilirubin are efficient coantioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(19)89449-8
– volume: 14
  start-page: 422
  year: 2008
  ident: 10.1016/j.cca.2010.06.003_bib31_2
  article-title: Role of heme oxygenase-1 in vascular disease
  publication-title: Curr Pharm Des
  doi: 10.2174/138161208783597335
– volume: 57
  start-page: 1526
  year: 2008
  ident: 10.1016/j.cca.2010.06.003_bib36
  article-title: Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance
  publication-title: Diabetes
  doi: 10.2337/db07-1764
– volume: 51
  start-page: 3120
  year: 2002
  ident: 10.1016/j.cca.2010.06.003_bib3
  article-title: Components of the metabolic syndrome and incidence of type 2 diabetes
  publication-title: Diabetes
  doi: 10.2337/diabetes.51.10.3120
– volume: 82
  start-page: 4196
  year: 1997
  ident: 10.1016/j.cca.2010.06.003_bib5
  article-title: Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.82.12.4196
– volume: 99
  start-page: 16093
  year: 2002
  ident: 10.1016/j.cca.2010.06.003_bib11
  article-title: Biliverdin reductase: a major physiologic cytoprotectant
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.252626999
– volume: 22
  start-page: 116
  year: 1993
  ident: 10.1016/j.cca.2010.06.003_bib24
  article-title: New method of measuring serum bilirubin using vanadic acid
  publication-title: Jpn J Clin Chem
– volume: 34
  start-page: 141
  year: 1983
  ident: 10.1016/j.cca.2010.06.003_bib35_1
  article-title: Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein
  publication-title: Adv Immunol
  doi: 10.1016/S0065-2776(08)60379-X
– volume: 5
  start-page: 105
  issue: 2
  year: 1997
  ident: 10.1016/j.cca.2010.06.003_bib21
  article-title: Are elevated aminotransferases and decreased bilirubin additional characteristics of the metabolic syndrome?
  publication-title: Obes Res
  doi: 10.1002/j.1550-8528.1997.tb00650.x
– volume: 132
  start-page: 195
  year: 1998
  ident: 10.1016/j.cca.2010.06.003_bib23
  article-title: Low density lipoprotein cholesterol can be chemically measured: a new superior method
  publication-title: J Lab Clin Med
  doi: 10.1016/S0022-2143(98)90168-8
– volume: 87
  start-page: 1196
  year: 2001
  ident: 10.1016/j.cca.2010.06.003_bib17
  article-title: Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study
  publication-title: Am J Cardiol
  doi: 10.1016/S0002-9149(01)01494-1
– volume: 58
  start-page: 1109
  year: 2009
  ident: 10.1016/j.cca.2010.06.003_bib40
  article-title: Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2009.04.003
– volume: 112
  start-page: 2735
  year: 2005
  ident: 10.1016/j.cca.2010.06.003_bib4
  article-title: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.105.169404
– volume: 10
  start-page: 539
  year: 2002
  ident: 10.1016/j.cca.2010.06.003_bib27
  article-title: A genome scan for loci influencing anti-atherogenic serum bilirubin levels
  publication-title: Eur J Hum Genet
  doi: 10.1038/sj.ejhg.5200842
– volume: 1158
  start-page: 189
  year: 1993
  ident: 10.1016/j.cca.2010.06.003_bib30_1
  article-title: A beneficial role of bile pigments as an endogenous tissue protector: anticomplement effects of biliverdin and conjugated bilirubin
  publication-title: Biochim Biophys Acta
  doi: 10.1016/0304-4165(93)90013-X
– volume: 14
  start-page: 79
  year: 2007
  ident: 10.1016/j.cca.2010.06.003_bib26
  article-title: Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction (PRIME)
  publication-title: Eur J Cardiovasc Prev Rehabil
  doi: 10.1097/01.hjr.0000230097.81202.9f
– volume: 136
  start-page: 383
  year: 1998
  ident: 10.1016/j.cca.2010.06.003_bib33_1
  article-title: Association of smoking and low serum bilirubin antioxidant concentrations
  publication-title: Atherosclerosis
  doi: 10.1016/S0021-9150(97)00232-3
– volume: 160
  start-page: 449
  year: 2002
  ident: 10.1016/j.cca.2010.06.003_bib34_1
  article-title: Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels
  publication-title: Atherosclerosis
  doi: 10.1016/S0021-9150(01)00601-3
– volume: 288
  start-page: 552
  issue: 3
  year: 2005
  ident: 10.1016/j.cca.2010.06.003_bib37
  article-title: The hyperbilirubinemic Gunn rat is resistant to the pressor effects of angiotensin II
  publication-title: Am J Physiol Ren Physiol
  doi: 10.1152/ajprenal.00278.2004
– volume: 14
  start-page: 79
  year: 2007
  ident: 10.1016/j.cca.2010.06.003_bib19
  article-title: Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction (PRIME)
  publication-title: Eur J Cardiovasc Prev Rehabil
  doi: 10.1097/01.hjr.0000230097.81202.9f
– volume: 25
  start-page: 1786
  year: 2005
  ident: 10.1016/j.cca.2010.06.003_bib33_2
  article-title: Heme oxygenase and atherosclerosis
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.0000178169.95781.49
– volume: 12
  start-page: 887
  year: 2001
  ident: 10.1016/j.cca.2010.06.003_bib18
  article-title: Serum bilirubin and 10-year mortality risk in a Belgian population
  publication-title: Cancer Causes Control
  doi: 10.1023/A:1013794407325
– volume: 28
  start-page: 166
  year: 2008
  ident: 10.1016/j.cca.2010.06.003_bib16
  article-title: Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.107.153262
– volume: 199
  start-page: 390
  year: 2008
  ident: 10.1016/j.cca.2010.06.003_bib12
  article-title: Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2007.11.022
SSID ssj0004061
Score 2.2001102
Snippet Studies on the effects of bilirubin on cardiovascular disease have typically focused only on total serum bilirubin composed with direct bilirubin plus indirect...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1496
SubjectTerms Adult
Bilirubin
Bilirubin - blood
Cardiovascular Diseases
Direct bilirubin
Fasting
Female
Humans
Indirect bilirubin
Korea
Male
Metabolic syndrome
Metabolic Syndrome - diagnosis
Metabolic Syndrome - epidemiology
Risk Factors
Sex Factors
Title Inverse relationship between fasting direct bilirubin and metabolic syndrome in Korean adults
URI https://dx.doi.org/10.1016/j.cca.2010.06.003
https://www.ncbi.nlm.nih.gov/pubmed/20542021
https://www.proquest.com/docview/749018410
Volume 411
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB5EQb2Ib9cXOXgS6rZN2rRHWZTVZT0peJHQtAmuaHfZx9Xf7kybKB7Wg6dCm9B0ZpL50vkyA3BBZLWM4oNRVcgAZ2IWZHklAiMsjrtApTc_3IYPaf9J3D8nzyvQ82dhiFbp1v52TW9Wa3en66TZnYxGdMY3pOKHlPMs5FlMJ8qFkGTlV58_NA9yWL6aGrX2kc2G44XDd-wuCknwZb5pGfZsfNDtNmw58Miu2_HtwIqpd2Gj52u27cL60IXK9-CFMmhMZ4ZNPd3tdTRhjpbFbDEjvjNrv54RQ3a6wE0yK-qKfZg5msb7qGQ-nwHDJ4Mx4ktsQAk7ZvvwdHvz2OsHrpZCUIoomwe4Ca6E5hrhAe4IS1mlScG1lmlBhS-4kIWwHOdvFJaGatckaS5NpEtuEysqa_kBrNbj2hwB0zpObCzxUpbCxia3uZBxaK3Vmeap7EDopahKl2ic6l28K88oe1MoeEWCVw2rjnfg8rvLpM2y8Vdj4VWjfpmKQi_wVzfm1ahQKxQXKWozXsyUFAiKMhGFHThs1fs9iBgRbYww6Ph_7zyBzYZtQISD_BRW59OFOUMQM9fnjZWew9r13aD_8AUsjO7-
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LT9wwEB5RkEovVYE-tg_woVwqpSS2EycHDogWLV2WE0hcKjdObHURZFebXVW99E_1D3YmsUEc4FCJU6TETqyZ8Twyn2cAPhJYLaf8YFKXKsKdmEd5UcvISofrLpHp3Q-38Wk2PJffLtKLFfgbzsIQrNLr_l6nd9ra39nz1NybTSZ0xjem5odU8ywWOVceWTmyv39h3NbuH39BJu9yfvT17HAY-dYCUSWTfBFhTFhLIwxaSwyQKlVnaSmMUVlJfSCEVKV0AsU5iStLrVzSrFA2MZVwqZO1cwLf-wTWJKoLapvw-c8troQsZGjfRssLqdQOVIb08nAyyoGI-4zhfc5uZ_SOXsBz762yg54gG7Bim01YPwxN4jbh6djn5rfgO5XsmLeWzQO-7udkxjwOjLmyJYA168nNCJI7X2JUzsqmZtd2gbJ4NalYKKDA8Mloig4tDqAKIe1LOH8UCr-C1Wba2DfAjOGp4wovVSUdt4UrpOKxc87kRmRqAHGgoq58ZXNqsHGlA4TtUiPhNRFedzA-MYBPN1NmfVmPhwbLwBp9RzY1mp2HprHARo1coURM2djpstVKoheWyyQewOuevTeL4OhCc_S73v7fN3dgfXg2PtEnx6ejd_CsgzoQ2qF4D6uL-dJ-QA9qYbY7iWXw47G3yD_nqylR
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Inverse+relationship+between+fasting+direct+bilirubin+and+metabolic+syndrome+in+Korean+adults&rft.jtitle=Clinica+chimica+acta&rft.au=Hwang%2C+Hee-Jin&rft.au=Kim%2C+Sang-Hwan&rft.date=2010-10-09&rft.issn=0009-8981&rft.volume=411&rft.issue=19-20&rft.spage=1496&rft.epage=1501&rft_id=info:doi/10.1016%2Fj.cca.2010.06.003&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_cca_2010_06_003
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-8981&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-8981&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-8981&client=summon